SV2009002991A - PHARMACEUTICAL COMPOSITION IN THE FORM OF ENCAPSULATED POWDERS UNDER ORLISTAT, COMPOSITION PREPARATION PROCEDURE AND ITS USE FOR THE TREATMENT OF OBESITY - Google Patents
PHARMACEUTICAL COMPOSITION IN THE FORM OF ENCAPSULATED POWDERS UNDER ORLISTAT, COMPOSITION PREPARATION PROCEDURE AND ITS USE FOR THE TREATMENT OF OBESITYInfo
- Publication number
- SV2009002991A SV2009002991A SV2008002991A SV2008002991A SV2009002991A SV 2009002991 A SV2009002991 A SV 2009002991A SV 2008002991 A SV2008002991 A SV 2008002991A SV 2008002991 A SV2008002991 A SV 2008002991A SV 2009002991 A SV2009002991 A SV 2009002991A
- Authority
- SV
- El Salvador
- Prior art keywords
- orlistat
- mix
- pharmaceutical composition
- composition
- obesity
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 3
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 title abstract 3
- 229960001243 orlistat Drugs 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 208000008589 Obesity Diseases 0.000 title abstract 2
- 235000020824 obesity Nutrition 0.000 title abstract 2
- 239000000843 powder Substances 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 abstract 5
- 238000010790 dilution Methods 0.000 abstract 3
- 239000012895 dilution Substances 0.000 abstract 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 abstract 2
- 239000000314 lubricant Substances 0.000 abstract 2
- 239000004094 surface-active agent Substances 0.000 abstract 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
- 239000001828 Gelatine Substances 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000007884 disintegrant Substances 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 229950004297 lauril Drugs 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229940023144 sodium glycolate Drugs 0.000 abstract 1
- 229910052938 sodium sulfate Inorganic materials 0.000 abstract 1
- 235000011152 sodium sulphate Nutrition 0.000 abstract 1
- 239000007921 spray Substances 0.000 abstract 1
- JEJAMASKDTUEBZ-UHFFFAOYSA-N tris(1,1,3-tribromo-2,2-dimethylpropyl) phosphate Chemical compound BrCC(C)(C)C(Br)(Br)OP(=O)(OC(Br)(Br)C(C)(C)CBr)OC(Br)(Br)C(C)(C)CBr JEJAMASKDTUEBZ-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A UNA COMPOSICIÓN FARMACÉUTICA ESTABLE DE ORLISTAT, EN LA FORMA DE UNA MEZCLA DE POLVO ENCAPSULADA, UN PROCEDIMIENTO PARA SU PREPARACIÓN Y AL USO DE LA COMPOSICIÓN PARA EL TRATAMIENTO DE LA OBESIDAD. LA COMPOSICIÓN FARMACÉUTICA COMPRENDE LOS SIGUIENTES EXCIPIENTES: 15-30% AGENTE ABSORBENTE DE HUMEDAD, TAL COMO LACTOSA SPRAY DRIED; 5-40% AGENTE DE DILUCIÓN, TAL COMO CELULOSA MICROCRISTALINA Y/O MANITOL GRANULAN 1-10% DESINTEGRANTE, TAL COMO ALMIDÓN GLICOLATO DE SODIO; 1-10% ANTIAGLOMERANTE, TAL COMO POLIENTILENGLICOL 4000; 0,5-2% SURFACTANTE, TAL COMO LAURIL SULFATO DE SODIO; UN GLIDANTE Y UN LUBRICANTE. EL PROCEDIMIENTO DE PREPARACIÓN DE LA COMPOSICIÓN CONSISTE EN MEZCLAR EL ORLISTAT, EL AGENTE ABSORBENTE DE HUMEDAD, UNA PRIMERA PARTE DEL GLIDANTE, EL ANTIAGLOMERANTE, Y OPCIONALMENTE UNA PRIMERA PARTE DEL AGENTE DE DILUCIÓN; MOLER ESTA MEZCLA; MOLER EL AGENTE DE DILUCIÓN REMANENTE, EL SURFACTANTE Y EL DESINTEGRANTE Y MEZCLAR CON LA PRIMERA MEZCLA; MOLER LA SEGUNDA PARTE DEL GLIDANTE Y EL LUBRICANTE, MEZCLAR CON LOS INGREDIENTES ANTERIORES Y ENCAPSULAR EN CÁPSULAS DE GELATINA DURATHE PRESENT INVENTION REFERS TO A STABLE PHARMACEUTICAL COMPOSITION OF ORLISTAT, IN THE FORM OF AN ENCAPSULATED POWDER MIX, A PROCEDURE FOR THEIR PREPARATION AND THE USE OF THE COMPOSITION FOR THE TREATMENT OF OBESITY. THE PHARMACEUTICAL COMPOSITION INCLUDES THE FOLLOWING EXCIPIENTS: 15-30% ABSORBING MOISTURE AGENT, SUCH AS LACTOSE SPRAY DRIED; 5-40% DILUTION AGENT, SUCH AS MICROCRYSTALLINE CELL AND / OR GRANULAN MANITOL 1-10% DISINTEGRANT, SUCH AS SODIUM GLYCOLATE ALMIDON; 1-10% ANTIAGLOMERANT, SUCH AS POLYENYLENE GLYCOL 4000; 0.5-2% SURFACTANT, SUCH AS LAURIL SODIUM SULPHATE; A GLIDANT AND A LUBRICANT. THE COMPOSITION PREPARATION PROCEDURE CONSISTS OF MIXING THE ORLISTAT, THE ABSORBING MOISTURE AGENT, A FIRST PART OF THE GLIDANT, THE ANTIAGLOMERANT, AND OPTIONALLY A FIRST PART OF THE DILUTION AGENT; MOLER THIS MIX; GRIND THE REMANENT DILUTION AGENT, THE SURFACTANT AND THE DISINSTANTANT AND MIX WITH THE FIRST MIXTURE; GRIND THE SECOND PART OF THE GLIDANT AND LUBRICANT, MIX WITH THE PREVIOUS INGREDIENTS AND ENCAPSULATE IN HARD GELATINE CAPSULES
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CL2007002287A CL53426B (en) | 2007-08-06 | 2007-08-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SV2009002991A true SV2009002991A (en) | 2009-04-16 |
Family
ID=51359501
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SV2008002991A SV2009002991A (en) | 2007-08-06 | 2008-07-31 | PHARMACEUTICAL COMPOSITION IN THE FORM OF ENCAPSULATED POWDERS UNDER ORLISTAT, COMPOSITION PREPARATION PROCEDURE AND ITS USE FOR THE TREATMENT OF OBESITY |
Country Status (7)
| Country | Link |
|---|---|
| CL (1) | CL53426B (en) |
| CR (1) | CR10132A (en) |
| DO (1) | DOP2008000021A (en) |
| MX (1) | MX2008010082A (en) |
| PA (1) | PA8786701A1 (en) |
| PE (1) | PE20091224A1 (en) |
| SV (1) | SV2009002991A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL216542B1 (en) * | 2008-03-20 | 2014-04-30 | Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna | Production method of a stable Orlistat composition in form of encapsulated powder |
-
2007
- 2007-08-06 CL CL2007002287A patent/CL53426B/es active
- 2007-10-25 PE PE2007001452A patent/PE20091224A1/en active IP Right Grant
-
2008
- 2008-04-10 DO DO2008000021A patent/DOP2008000021A/en unknown
- 2008-07-01 PA PA20088786701A patent/PA8786701A1/en unknown
- 2008-07-07 CR CR10132A patent/CR10132A/en not_active Application Discontinuation
- 2008-07-31 SV SV2008002991A patent/SV2009002991A/en unknown
- 2008-08-06 MX MX2008010082A patent/MX2008010082A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| MX2008010082A (en) | 2009-04-17 |
| CL2007002287A1 (en) | 2007-12-14 |
| CL53426B (en) | 2016-11-28 |
| PA8786701A1 (en) | 2009-04-23 |
| CR10132A (en) | 2008-10-28 |
| DOP2008000021A (en) | 2009-11-30 |
| PE20091224A1 (en) | 2009-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY29410A1 (en) | PHARMACEUTICAL COMPOSITIONS BASED ON METHODAMIDES OF ACID 4- (4 - / - 3 (-4-CHLORO-3-TRIFLUOROMETIFENIL) UREIDO) FENOXI) PIRIDIN-2-CARBOXYLIC, PREPARATION PROCEDURE AND APPLICATIONS. | |
| IS8669A (en) | Rasagiline formulations in which the homogeneity of the ingredients has been improved | |
| CO6761350A2 (en) | Derivatives of 2,3-dihydroimidazo [1,2-c] quinazoline substituted with amino alcohols that are useful for treating hyperproliferative disorders and diseases associated with angiogenesis | |
| MX2017010220A (en) | FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS WITH CONTROLLED ABSORPTION PROFILE. | |
| ECSP077299A (en) | NEW PHARMACEUTICAL COMPOSITIONS THAT INCLUDE ACID 4- (4- (3- (4-CHLORO-3-TRIFLUOROMETIL-FENIL) -UREIDO) -3-FLUORO-PHENOXI) -PIRIDIN-2-CARBOXYLIC FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS | |
| UA106877C2 (en) | An extended release pharmaceutical composition of entacapone or salts thereof | |
| SG190448A1 (en) | Rapidly dispersing granules, orally disintegrating tablets and methods | |
| CL2007003356A1 (en) | COMPOUNDS DERIVED FROM BENZOPIRAZOLES; PROCESS FOR THE PREPARATION OF SUCH COMPOUNDS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS AND ANOTHER ACTIVE AGENT; AND ITS USE FOR THE TREATMENT OF ASTHMA, INFLAMMATION, AMONG OTHER DISEASES. | |
| BRPI0606332A2 (en) | bendamustine pharmaceutical composition, lyophilized preparation, pharmaceutical dosage form, method for obtaining official approval for a bendamustine product, process for making a lyophilized bendamustine preparation, bendamustine pre-lyophilization solution or dispersion, lyophilized powder, method for preparing a lyophilized preparation of bendamustine, formulation for lyophilization, and use of a pharmaceutically acceptable solution | |
| EA201001852A1 (en) | SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING BIBW 2992 | |
| CR10349A (en) | FAST LIBERATION PARACETAMOL TABLETS | |
| CU20200008A7 (en) | SUBSTITUTE DIHYDROOXADIAZINONE COMPOUNDS USEFUL IN THE TREATMENT OF HYPERPROLIFERATIVE DISEASES, METHODS FOR PREPARING SUCH COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| BR112015020443A2 (en) | Demorphization of spray-dried formulations via spray mixture | |
| BR112018074381A2 (en) | [8- (phenylsulfonyl) -3,8-diazabicyclo [3.2.1] oct-3-yl] (1h-1,2,3-triazol-4-yl) methanones | |
| WO2009120389A8 (en) | Oral and injectable formulations of tetracycline compounds | |
| AR102779A1 (en) | PHARMACEUTICAL COMPOSITION, ITS PREPARATION AND ITS USES | |
| MX375427B (en) | COMPOSITION COMPRISING AT LEAST ONE DRY POWDER OBTAINED BY SPRAY DRYING TO INCREASE THE STABILITY OF THE FORMULATION | |
| ES2922903T3 (en) | Pharmaceutical composition comprising salts of lenvatinib | |
| MY159317A (en) | Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus | |
| UY37538A (en) | AROMATIC AMIDES OF CARBOXYLIC ACIDS | |
| WO2011090724A3 (en) | Gastroretentive solid oral dosage forms with lipid-based low-density excipient | |
| SV2009002991A (en) | PHARMACEUTICAL COMPOSITION IN THE FORM OF ENCAPSULATED POWDERS UNDER ORLISTAT, COMPOSITION PREPARATION PROCEDURE AND ITS USE FOR THE TREATMENT OF OBESITY | |
| CL2007003160A1 (en) | COMPOUNDS DERIVED FROM PIRIDINA; PREPARATION PROCEDURE; PHARMACEUTICAL FORMULATION; AND USE IN THE TREATMENT OF SUCH DISEASES AS THROMBOSIS, RENAL FIBROSIS, ISCHEMIA, AMONG OTHERS. | |
| MX2008003422A (en) | COMPOSITIONS THAT INCLUDE AT LEAST A NAFTOIC ACID DERIVATIVE AND AT LEAST A POLYURETHANE POLYMER TYPE COMPOSITE OR DERIVATIVES, PREPARATION PROCESSES AND COMPOSITIONS THAT INCLUDE AT LEAST A NAFTOIC ACID DERIVATIVE AND AT LEAST | |
| EP3354283A3 (en) | Pharmaceutical capsule composition comprising silodosin |